Initial effects include increased energy and improved mental clarity within the first week
In fact, even when development as a prescription obesity drug slowed (after some longer trials showed only modest results), AOD-9604 found new life as a wellness peptide due to its excellent safety profile
nov., sp
doi:10.1016/j.jand.2016.09.025
Current evidence suggests: Positive Safety Indicators: No toxicity observed in animal studies at therapeutic doses Selective mechanism reduces off-target effects No evidence of organ damage or dysfunction Reversible effects upon discontinuation Areas Requiring Further Study: Long-term effects on NNMT function Impact on methylation processes over extended periods Potential effects on fertility and reproduction Interactions with aging processes Regulatory Status and Quality Considerations 5-Amino-1MQ is not FDA-approved for any medical use and exists as a research compound
Important safety questions include product purity, dose accuracy, drug interactions, liver and kidney considerations, blood sugar changes, cardiovascular risk, pregnancy or breastfeeding status, and long-term exposure